GERN vs LVS · rev $109.3M vs P/E 28, rev $6.74B
Geron Corporation (GERN) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
GERN currently screens at market cap $878.9M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the GERN and LVS stock pages for the full models.
Not investment advice.